Understood reports GLP-1 drugs like Ozempic may improve ADHD symptoms by quieting food thoughts, but more research is needed for direct effects.

New research suggests GLP-1 drugs may increase the risk of bone and tendon injuries and other conditions, including ...

Newsweek compares and contrasts AWS' and Salesforce's new AI agent suites after exclusive interviews with top execs.

The blockbuster GLP-1 drugs that have reshaped the treatment of diabetes and obesity may help prevent multiple substance use disorders — and reduce the tragic outcomes they cause, a large new study ...

Kelly Grant and Chris Hannay answered reader questions on the rise of Ozempic and similar drugs in Canada, what experts are ...

New research suggests the weight-loss medications could be powerful tools in tackling substance use disorders.

Evidence is mounting that the wildly popular weight-loss medicines known as GLP-1s may also hold potential for treating addiction, and the field may be on the verge of obtaining desperately needed ...

A woman with multiple sclerosis wanted to be able to walk up the stairs at home without losing her balance. Her doctor prescribed medicine that helped, but then approval from ...

In this first episode of a three-part Business Daily series on the global weight-loss economy, Sam Fenwick examines the real ...

Submit an appeal, even if you're worried you’ll lose. Yaver said that, based on the research set to be published in her book, Coverage Denied: How Health Insurers Drive Inequality in the United States ...

These health care hurdles can stand in the way of getting treatment your doctor says you need. Here’s what to know about how ...

Thirty years after its discovery, scientists are eyeing leptin with renewed interest, for everything from weight loss drug ...